// App-Quantinova.ai

10133 : Efficacy of selective screening in identifying patients with hepatitis B before cancer therapy.

Researchers

Presenter

  • Jessica Hwang

Principal Investigators

  • Anna S. F. Lok

  • Scott B. Cantor

  • Michael Fisch

  • Andrea G. Barbo

  • Heather Y. Lin

  • Maria E. Suarez-Almazor

Medical Centers

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • University of Michigan, Ann Arbor, MI

  • AIM Specialty Health, Chicago, IL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hepatitis B

  • Solid malignancies

Biomarkers

  • Hepatitis B surface antigen

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved